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Abstract
Caveolin-1 (Cav1) is a scaffold protein and pathogen receptor in the mucosa of the gastrointestinal tract. Chronic infection
of gastric epithelial cells by Helicobacter pylori (H. pylori) is a major risk factor for human gastric cancer (GC) where Cav1 is
frequently down-regulated. However, the function of Cav1 in H. pylori infection and pathogenesis of GC remained unknown.
We show here that Cav1-deficient mice, infected for 11 months with the CagA-delivery deficient H. pylori strain SS1,
developed more severe gastritis and tissue damage, including loss of parietal cells and foveolar hyperplasia, and displayed
lower colonisation of the gastric mucosa than wild-type B6129 littermates. Cav1-null mice showed enhanced infiltration of
macrophages and B-cells and secretion of chemokines (RANTES) but had reduced levels of CD25+ regulatory T-cells. Cav1-
deficient human GC cells (AGS), infected with the CagA-delivery proficient H. pylori strain G27, were more sensitive to CagA-
related cytoskeletal stress morphologies (‘‘humming bird’’) compared to AGS cells stably transfected with Cav1 (AGS/Cav1).
Infection of AGS/Cav1 cells triggered the recruitment of p120 RhoGTPase-activating protein/deleted in liver cancer-1
(p120RhoGAP/DLC1) to Cav1 and counteracted CagA-induced cytoskeletal rearrangements. In human GC cell lines (MKN45,
N87) and mouse stomach tissue, H. pylori down-regulated endogenous expression of Cav1 independently of CagA.
Mechanistically, H. pylori activated sterol-responsive element-binding protein-1 (SREBP1) to repress transcription of the
human Cav1 gene from sterol-responsive elements (SREs) in the proximal Cav1 promoter. These data suggested a
protective role of Cav1 against H. pylori-induced inflammation and tissue damage. We propose that H. pylori exploits down-
regulation of Cav1 to subvert the host’s immune response and to promote signalling of its virulence factors in host cells.
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Introduction
Helicobacter pylori (H. pylori) is a Gram-negative bacterium which
colonizes stomachs of approx. 50% of the world’s population and
increases the risk for development of chronic gastritis, peptic ulcer
disease, gastric mucosa-associated lymphoid tissue (MALT)
lymphoma, mucosal atrophy and gastric cancer (GC) [1,2]. Based
on this etiology, H. pylori has been classified as a class I carcinogen
by the World Health Organisation (WHO) in 1994 [3].
The two major H. pylori toxins [4], CagA and VacA, are
internalized into gastric epithelial cells by injection via the
bacterial type IV secretion system (CagA) [5] or by direct insertion
into lipid rafts (VacA) [6,7]. Lipid rafts are cholesterol and
sphingolipid-rich microdomains of the plasma membrane [8,9]
which are exploited by many pathogens, including viruses,
parasites and bacteria, to facilitate uptake of whole organisms
and/or internalisation of toxins into host cells [10,11,12]. For
example, Neisseria spec. uses lipid rafts and Rho-mediated signaling
of the actin cytoskeleton to gain access to the cytosol [13].
Pseudomonas aeruginosa exploits lipid raft-associated toll-like receptor
2 for infection of lung epithelial cells [14].
Caveolin-1 (Cav1) is the 21–24 kDa major and essential
structural protein of caveolae, a specialized form of lipid raft
microdomains. Caveolae are 50–100 nm flask/tube-shaped in-
vaginations of the plasma membrane abundant in macrophages,
endothelial and smooth muscle cells, type I pneumocytes and
adipocytes, where they participate in cellular transport processes
including endocytosis, cholesterol efflux and membrane traffic
[15,16]. In this context, Cav1 can also act as an inhibitor of
clathrin-independent endocytosis and block pathogen/toxin up-
take [17,18]. Through binding to its scaffolding domain, Cav1
directly inhibits a plethora of receptors and enzymes including
tyrosine kinases of the Src and Ras family, G-proteins and nitric
oxide synthases [15]. In addition to a role in membrane traffic,
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Cav1 thus constitutes a control platform for regulation of cell
proliferation and survival [19]. Cav1 also exerts an important
function in cell motility and migration and, within epithelial,
stromal and endothelial tissues, by enforcing cell-cell contacts, cell-
matrix adhesion and immune responses [20,21,22,23].
Cav1 directly binds cholesterol, and transcription of Cav1 is
negatively regulated by the transcription factor sterol-responsive
element-binding protein-1 (SREBP1) [24]. SREBP1 is bound to
the endoplasmic reticulum (ER) as an inactive 125 kDa precursor
and is activated under conditions of cholesterol deficiency by
proteolytic cleavage in the Golgi apparatus. This cleavage is
followed by translocation of the active 68 kDa SREBP1 into the
nucleus where it binds to sterol-responsive elements (SREs) of
target genes, including Cav1, involved in synthesis of cholesterol
and fatty acids [25]. H. pylori has been shown to metabolize
cholesterol from the host cell membrane, and host cholesterol
alters the oncogenic properties of CagA [26,27].
We therefore hypothesized that the cholesterol-binding proteins
SREBP1 and Cav1 are targets of H. pylori infection and/or effector
functions. Specifically, we asked whether (i) H. pylori exploits Cav1
to facilitate injection and down-stream signalling of CagA in
gastric epithelial cells or (ii) Cav1 acts as a protective ‘‘barrier-
enforcing’’ protein that counteracts disease evoked by H. pylori. To
test this, the phenotypes which result from H. pylori infection were
studied in Cav1-deficient mice and in human GC cell lines. Our
data showed that Cav1 protected B6129 mice against H. pylori-
related gastritis and tissue damage in vivo independently of CagA.
H. pylori also activated SREBP1 and down-regulated expression of
murine and human Cav1 independently of CagA. In addition,
Cav1 counteracted CagA-dependent cytoskeletal rearrangements
in vitro by recruitment of the tumor suppressor deleted in liver
cancer-1 (DLC1).
Materials and Methods
Ethics statement
Animal studies were conducted in agreement with the ethical
guidelines of the Technische Universita¨t Mu¨nchen (German
Animal Welfare Act, Deutsches Tierschutzgesetz) and had been
approved (#55.2-1-54-2531-74-08) by the government of Bavaria
(Regierung von Obb., Munich, Germany).
Animals
Homozygous Cav1 knockout (Cav1-KO) (strain Cav1tm1Mls/
J; stock number 004585) and matched control wild-type (WT)
(strain B6129SF2/J; stock number 101045) mice (8 weeks) were
obtained from the Jackson Laboratory (Bar Harbor, Maine) and
maintained on a mixed background in a pathogen-free mouse
facility [28,29]. Experimental gastric ulceration was performed
with indomethacin as published before [30]. Infection of mice with
the mouse-adapted CagA/VacA-delivery deficient H. pylori strain
SS1 was performed by oral gavage as described [31]. The average
time mice from different genetic backgrounds (C57BL/6, B6129,
BALB/c) take to progress to chronic gastritis and beyond (gastric
atrophy, hyperplasia, dysplasia) [32] ranges between 10 and 15
month upon infection with the standardized reference strain SS1
[28,33,34,35]. We therefore decided to perform our analysis
within this time frame.
Reagents
Chemicals were from Merck (Darmstadt, Germany) or Sigma
(Taufkirchen, Germany). Polyclonal antisera were SREBP1 (#PA1-
46142, Thermofisher Scientific, Waltham, MA), Cav1 (N-20, sc-
894), SREBP1 (C-20, sc-366), CagA (b-300, sc-25766), FAK (A-17,
sc-557), phospho-FAK (Tyr-397, sc-11765), Hsp90 alpha/beta (H-
114, sc-7947), Lamin A/C (H-110, sc-20681, all from Santa Cruz
Biotech., CA), general and phospho ERK1/2 (p44/p42), p38, JNK
(all from Cell Signaling, Danvers, MA) and Ki-67 (SP6, DCS
GmbH, Hamburg, Germany). Mouse monoclonal antibodies were
Cav1 (#610406) and phospho-Cav1 (pY14, #611338) (both from
BD/Transduction Lab., San Jose, CA), DLC-1 (C-12, sc-271915)
and beta-Actin (AC-15, sc-69879) (both from Santa Cruz Biotech.).
The macrophage-specific rat anti-mouse F4/80 antibody
(#MF48000) was obtained from Invitrogen (Life Technologies,
Darmstadt, Germany). Chicken anti-H. pylori polyclonal Ab was
used as described [36]. Serum cytokines were measured by ELISA
(R&D Systems, Minneapolis, MN) according to the manufacturer’s
instructions. Pull-down assays for the small GTPases Rho/Rac/
Cdc42 were purchased from Biocat (Heidelberg, Germany).
Cell culture
Human embryonic kidney (HEK293), Madin-Darby canine
kidney (MDCK), parental human GC cell lines (AGS, MKN45,
N87) (all from the American Type Culture Collection, Rockville,
MD) and stably transfected clones generated thereof were
maintained as described previously [37]. Infection of cells with
the cell-adapted CagA-delivery proficient H. pylori strain G27 was
performed as before [36].
DNA-constructs
The expression plasmid pEGFP-CagA was mentioned else-
where [38]. The ,800 bp fragment of the proximal human Cav1
promoter (AF019742, position 69 to 859) [24] was amplified by
PCR from the genomic DNA of human normal liver and cloned
into the KpnI/HindIII sites of pGL3-luc luciferase reporter
plasmid (Promega GmbH, Mannheim, Germany). Isoform 4 of
the human DLC1 mRNA [39] (DLC1v4, NM_001164271.1) was
amplified from human hepatoma HepG2 cells and inserted in the
BamHI/NotI sites of the expression vector pTarget (pT, Promega
GmbH). Transient transfection and luciferase assays were
performed as before [37].
Author Summary
Infection with the bacterium Helicobacter pylori (H. pylori)
mainly affects children in the developing countries who
are at risk to progress to gastric cancer (GC) as adults after
many years of persistent infection, especially with strains
which are positive for the oncogenic virulence factor CagA.
Eradication of H. pylori by antibiotics is a treatment of
choice but may also alter the susceptibility to allergies and
other tumor types. Thus, novel diagnostic or prognostic
markers are needed which detect early molecular changes
in the stomach mucosa during the transition of chronic
inflammation to cancer. In our study, we found that the
tumor suppressor caveolin-1 (Cav1) is reduced upon
infection with H. pylori, and CagA was sufficient but not
necessary for this down-regulation. Loss of Cav1 was
caused by H. pylori-dependent activation of sterol-respon-
sive element-binding protein-1 (SREBP1), and this event
abolished the interaction of Cav1 with p120 RhoGTPase-
activating protein/deleted in liver cancer-1 (p120RhoGAP/
DLC1), a second bona fide tumor suppressor in gastric
tissue. Conclusively, Cav1 and DLC1 may constitute novel
molecular markers in the H. pylori-infected gastric mucosa
before neoplastic transformation of the epithelium.
Caveolin-1 and Helicobacter pylori
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Bacterial culture
H. pylori SS1 and G27 bacteria were recovered from 280uC
glycerol stocks and grown on Wilkins-Chalgren (WC) blood
agar plates under microaerobic conditions (10% CO2, 5% O2,
85% N2; 37uC) for 2–3 days. The mouse-adapted H. pylori SS1
was harvested from agar plates for in vivo infections as
published previously [31]. The SS1 strain was PCR-positive
for the cagA gene and mRNA but did not inject functional
CagA protein [40] as evident by the absence of the ‘‘humming
bird’’ phenotype in infected AGS cells (data not shown). The
cell-adapted H. pylori bacteria CagA-delivery proficient G27 wt
and the CagA-deletion mutant G27 Delta cagA were harvested
from agar plates and subsequently grown in continuous co-
culture with MDCK cells as described [36].
Ex vivo quantification of colony forming units (CFUs)
Whole stomachs were excised from mice, and colony formation
was determined essentially as described [31]. An antral strip of the
stomach was weighed, placed into 5 ml of Brucella broth and
vortexed for 10 min. Dilutions of 1:10, 1:100 and 1:1000 were
prepared, and 100 ml of each dilution was plated onto H. pylori-
selective WC blood agar plates. The number of bacterial colonies
was determined after 5 days and normalised to the weight of the
corresponding stomach pieces.
Processing of mouse gastric tissue
The remaining stomach was washed with sterile water. An
antral strip was cut, frozen in liquid nitrogen and stored at 280uC
until RNA extraction. The rest of the stomach was placed into
3 ml of 4% (w/v) paraformaldehyde (PFA) in phosphate buffered
saline (PBS) and incubated for 24 h at 4uC. Then, the stomach was
cut along the greater and small curvature into two halves, followed
by dehydration and embedding into paraffin for histological
analysis.
Gentamycin protection assay
Cells were infected with the H. pylori G27 strain for 2 to 24 h at
a multiplicity of infection (MOI) of 500:1. Thereafter, cells were
washed three times with PBS to remove residual bacteria and were
additionally incubated for 2 h at 37uC in a humidified atmosphere
in DMEM/F12 (10% FCS, 10% Brucella broth) supplemented
with gentamycin (200 mg/ml), penicillin/streptomycin (100 mg/
ml) and chloramphenicol (100 mg/ml). Absence of extracellular
bacteria was confirmed under the microscope, and the cells were
subsequently lysed for detection of intracellular CagA by Western
blot (WB).
Coimmunoprecipitation (CoIP) and Western blot (WB)
Detection of immunoprecipitated proteins by SDS-PAGE and
WB was performed as before [41]. Matrix-assisted Laser
Desorption/Ionization mass spectrometry (MALDI-MS) was
described in detail in [29].
Immunofluorescence
The staining was performed in triple-color mode visualizing 4,6-
diamidino-2-phenylindole (DAPI), Alexa-488 and -594 using a
digital camera-connected (Axiovision, release 4.4) fluorescence
microscope (Axiovert 200M, Carl Zeiss MicroImaging GmbH,
Hallbergmoos, Germany). Confocal microscopy (Axiovert 40,
Zeiss) and 3D-reconstruction of H. pylori-infected cells with
LSM510 (Zeiss) and Volocity (Improvision, Tu¨bingen, Germany)
was done as before [37].
Histopathological evaluation and immunohistochemistry
(IHC)
Chronic active gastritis was defined by the simultaneous
presence of both neutrophilic polymorphnuclear (PMN) and
mononuclear cells (lymphocytes and plasma cells) within the
gastric mucosa. Active (PMN) and chronic (mononuclear) infiltrate
was assessed as follows: Paraffin-embedded gastric tissue was cut
into 3 mm sections using a semi-automatic microtome (Leica
Microsystems GmbH, Wetzlar, Germany). The sections were then
stained using Hematoxylin & Eosin (H&E) solutions. The
histopathological analysis was carried out by three pathologists
(CR, SR, TK) blinded to the study setup. Morphological
alterations in the gastric mucosa were classified according to the
updated Sydney system [32,42]. The grade of gastritis was scored
based on the density of intramucosal inflammatory infiltrates from
mononuclear and PMN cells as published before [43]: none (0),
mild (1+), moderate (2+) and severe (3+). In addition, hyperplastic
or regenerative epithelial alterations, loss of parietal cells and the
frequency of lymphoid follicles or lymphoid aggregates were
noted. The intensity of H. pylori colonization in the gastric mucosa
was recorded as mild (few and single bacteria in a random
distribution), moderate (single and clustered bacteria in a
discontinuous distribution) and severe (dense bacterial clusters
covering the gastric mucosa in continuous layers). Multiple scores
of different regions of the stomach were determined. Immunohis-
tochemistry (IHC) was performed on paraffin sections as described
before [44].
Electrophoretic mobility shift assay (EMSA), chromatin
immunoprecipitation (ChIP), reverse transcription PCR
(RT-PCR) and quantitative PCR (qPCR)
ChIP (Kit from Upstate, Millipore GmbH, Schwalbach,
Germany) and all other methods were performed as described
previously [45]. Oligonucleotides are listed in Table S1.
Cellular assays
Viability of adherent cells was measured by 1-(4,5-dimethylthia-
zol-2-yl)3,5-diphenyl-formazan (MTT) assay (Roche Diagnostics
GmbH, Mannheim, Germany) as recommended by the manu-
facturer. To determine cell adhesion, 16104 cells were seeded into
6 cm cell culture dishes for 1 to 6 h followed by repetitive washing
with PBS. The remaining adherent cells were fixed with 4% (w/v)
PFA in PBS, stained with crystal violet and subsequently counted
using ImageJ (NIH, Bethesda, MD). Wound healing assays were
performed essentially as described in [46]. Briefly, cells were
grown to confluence in 6 cm dishes, and a 5 mm scratch was
introduced into the monolayer using an inverted blue tip followed
by incubation of the cell culture plates for additional 24, 48 and
72 h. Wound closure was monitored upon fixation and staining of
cells with crystal violet using bright field microscopy (Axiovert
200M, Carl Zeiss MicroImaging GmbH).
Statistics
Results are means 6 S.E. from at least 5 animals per genotype
or 3 independent experiments from different cell passages. The
software GraphPad Prism (version 4.0, La Jolla, CA) was used to
analyze the data. P-values (*p,0.05) were calculated using
Student’s t and Fisher Exact tests.
Accession numbers
Human: Cav1: NM_001753.4, Q03135; b2M: NM_004048.2,
P61769; IL8: NM_000584.3, P10145; DLC1 v1: NM_182643.2,
Q96QB1; DLC1 v4: NM_001164271.1, Q96QB1; ACS:
Caveolin-1 and Helicobacter pylori
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NM_018677.3, Q9NR19; HMGCoAS: NM_001098272.2,
Q01581; HMGCoAR: NM_000859.2, P04035; LDLR:
NM_000527.4, P01130; beta-Actin: P60709; Lamin A: P02545;
Lamin C: P02545; Hsp90 alpha: P07900; Hsp90 beta: P08238;
ERK1 (p44): P27361; ERK2 (p42): P28482; FAK: Q05397;
JNK1: P45983; JNK2: P45984; p38: Q16539; Src: P12931;
SREBP1: P36956; Ki-67: P46013; Mouse: Cav1: NM_007616.4,
P49817; b2M: NM_009735.3, Q91XJ8; TNFalpha:
NM_013693.2, P06804; IFNgamma: NM_008337.3, P01580;
IL1beta: NM_008361.3, P10749; IL6: NM_031168.1, P08505;
CD4: NM_013488.2, P06332; CD19: NM_009844.2, P25918;
CD25: NM_000417.2, P01589; CD86: NM_019388.3, P42082;
CCL5: NM_013653.3, P30882; CXCL1: NM_008176.3, P12850;
PPARg2: NM_015869.4, P37231; TFF2: NM_009363.3,
Q9QX97; Dog: b2M: NC_006612, XP_850148; H. pylori: CagA:
YP_002266135.1, B5Z6S0; UreB: YP_626814.1, Q1CV82.
Results
Cav1-deficient mice display enhanced gastritis upon
infection with CagA-delivery incompetent H. pylori SS1
To assess the histological changes induced in gastric tissue upon
H. pylori infection, B6129 WT and Cav1-KO mice were infected
with the mouse-adapted and CagA-delivery deficient H. pylori
strain SS1. The mice were euthanized 11 months later, and H.
pylori was isolated from resected stomach tissue [31]. Cav1-KO
mice showed less bacterial colonisation of the gastric mucosa than
WT mice (7.362.4 WT versus 1.660.5 KO 6103 CFU/mg
stomach tissue; *p = 0.0141; n = 15 per genotype) (Fig. 1A).
Histopathological analysis revealed that both WT and Cav1-KO
mice developed active chronic gastritis accompanied by infiltration
of mononuclear and polymorphnuclear (PMN) cells into the
gastric mucosa (Fig. 1B). In contrast, uninfected WT and Cav1-
KO mice had no intramucosal inflammation (data not shown).
Instead, the gastritis was markedly enhanced in H. pylori-infected
Cav1-KO mice compared with infected WT mice (Fig. 1C). In
Cav1-KO mice, the average score of gastritis (0.760.2 WT versus
1.760.1 KO; *p= 0.0002, n= 15 per genotype) was more severe
(Table 1) than in WT mice, and the stomach mucosa exhibited
intramucosal B-cell follicles, foveolar hyperplasia and loss of
parietal cells. This data indicate that Cav1-deficiency is associated
with an increased inflammatory response in the gastric mucosa
and a less efficient colonisation by H. pylori.
Cav1-deficiency promotes recruitment of macrophages
into the infected gastric mucosa
To assess the identity of immune cells which contribute to H.
pylori-related inflammation in Cav1-KO mice, RT-qPCR analysis
of selected cytokines, surface markers and chemokines was
performed (Fig. 2A). Consistent with the observed inflammation,
H. pylori SS1 induced expression of TNFalpha and IFNgamma in
the gastric mucosa of both WT and KO mice. In addition, we
stated an increased mRNA expression of CD19 (B-cells) (1.660.3
WT versus 3.360.9 KO; p=0.0512; n= 15 per genotype) and
RANTES (CCL5) (1.360.2 WT versus 2.160.6 KO; p=0.0449;
n = 15 per genotype) in gastric tissue of H. pylori-infected Cav1-KO
mice compared with infected WT mice. In contrast, mRNA levels
of CD4 (T-helper cells), CD25 (T-regulatory cells) and CD86
(antigen-presenting cells) were suppressed by H. pylori indepen-
dently of the Cav1 status. Immunohistochemistry (IHC) detected a
marked increase of intramucosal F4/80-positive macrophages in
gastric tissue of infected Cav1-KO mice compared with WT
littermates (Fig. 2B). CD3-positive lymphocytes were located
around and within intramucosal follicles (data not shown).
Similar results were obtained from experiments introducing
rapid gastric injury in mice by injection of indomethacin [30]
(Fig.S1). Consistent with the enhanced tissue damage in Cav1-
KO stomachs (*p= 0.0161, WT versus KO, n=9 per genotype),
characterized by inflammation, erosion and ulceration, Cav1-
deficient mice also expressed higher amounts of mRNAs encoding
for the ulcer healing proteins trefoil factor-2 (TFF2) (0.860.3 WT
versus 2.360.4 KO; *p= 0.0048; n = 9 per genotype) and
peroxisome proliferator-activated receptor-gamma (PPARg)
(0.660.2 WT versus 2.560.5 KO; *p= 0.0008; n = 9 per geno-
type). In sum, these data indicated that loss of Cav1 enhances the
susceptibility of mice to gastric inflammation and tissue damage.
Cav1 neither alters adhesion of H. pylori strains to nor
survival of human GC cells
To assess the function of Cav1 during H. pylori infection in vitro,
the human gastric epithelial cell line AGS was used which had
been stably transfected with Cav1 expression plasmid (AGS/Cav1)
or empty vector (AGS/EV) [37]. First, we examined whether
Cav1 influences cell survival upon H. pylori infection (Fig. 3A).
AGS clones with and without Cav1 were infected for 48 h with the
cell-adapted CagA-delivery competent H. pylori strain G27 at
different multiplicities of infection (MOI) ranging from 1:100 to
1:2000. Colorimetric MTT assays revealed that Cav1 had no
effect on overall survival of AGS cells upon H. pylori infection.
Similar results were obtained with CagA-delivery incompetent H.
pylori SS1 and by Western blot (WB) analysis detecting the
expression and phosphorylation of survival kinases (AKT/PKB,
ERK1/2, p38MAPK) (data not shown). Since both H. pylori and
Cav1 interact within lipid rafts, we asked whether adhesion of
bacteria to cells depends on the presence of Cav1. AGS/Cav1 and
AGS/EV cells were infected (MOI=10) with G27 (Fig. 3B,C) or
SS1 (data not shown) bacteria for 30 min, followed by washing
and subsequent incubation in fresh medium for 2 h. Thereafter,
cells were stained for immunofluorescence microscopy, and the
number of bacteria which adhered to the Cav1-expressing or
empty vector-transfected cells were counted (Fig. 3B,C). No
differences in adhesion were observed between AGS/Cav1 and
AGS/EV cells, suggesting that Cav1 does not influence adhesion
of H. pylori bacteria to host cells.
Cav1 protects human GC cells against CagA-induced
rearrangement of the cytoskeleton
The formation of needle-like projections (‘‘humming bird’’) is a
typical morphological phenotype of AGS cells in response to
infection with CagA-delivery proficient H. pylori strains and
translocation of CagA into the cytosol [47]. To examine the role
of Cav1 in this stress-induced rearrangement of the actin
cytoskeleton, AGS/Cav1 and AGS/EV were infected for 16 h
with H. pylori G27 wt or the isogenic mutant Delta cagA
(MOI= 100). Infected cells were stained as described above, and
the numbers of elongated AGS cells were determined (Fig. 4A,B).
Cav1-deficient AGS cells showed considerably more elongated
morphologies than Cav1-expressing cells (1160.8% AGS/EV
versus 460.8% AGS/Cav1; *p = 1.161028; n = 3 per clone). As
expected, no ‘‘humming bird’’ phenotype was obtained in cells
infected with the CagA-delivery deficient SS1 or the CagA-
deletion mutant G27 Delta cagA strains which are both unable to
inject functional CagA protein into the host cells (data not shown).
AGS/EV cells also produced more IL8 mRNA upon H. pylori G27
infection than AGS/Cav1 cells (64619 EV versus 1966 Cav1;
*p = 0.0176; n= 3 per clone) (Fig. 4C). These data indicated that
Cav1 protects against CagA-related cell stress.
Caveolin-1 and Helicobacter pylori
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In support of these findings, cell adhesion and wound closure
rates were more pronounced in AGS/Cav1 compared with AGS/
EV cells (Fig.S2). Consistent with its function as a target protein of
CagA and component of focal adhesions [48], WB analyses
(Fig. 4D) also detected higher levels (0.460.1 AGS/EV versus
1.460.1 AGS/Cav1, *p = 0.0012; n= 3 per clone) of phosphor-
Figure 1. Cav1-deficient mice show enhanced gastritis upon infection with H. pylori SS1. B6129 WT and Cav1-KO mice (n = 15 per group)
were infected with the mouse-adapted CagA-delivery incompetent H. pylori SS1 strain for 11 month. (A) Stomachs of Cav1-KO mice were less
colonized by SS1 bacteria than those of WT mice. Ex vivo quantification of colony forming units (CFUs) per mg of resected stomach tissue. The data
are presented as mean 6 S.E. (n = 15 per group); *p = 0.0141 KO versus WT. (B–C) Hematoxylin & Eosin (H&E) and Warthin-Starry silver (WS) stainings
from paraffin sections of mouse gastric tissue were evaluated for signs of histopathology and results were scored for individual mice (0+ no, 1+mild ,
2+ moderate, 3+ severe gastritis). Data are presented as in (A) (n = 15 per group); *p = 0.0002 KO versus WT. Cav1-KO mice show active chronic
gastritis with intramucosal lymphocyte follicles, foveolar hyperplasia and loss of parietal cells. Quantitative analyses (B) are shown together with
representative histology (C); magnifications 1006, 2006.
doi:10.1371/journal.ppat.1003251.g001
Caveolin-1 and Helicobacter pylori
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ylated focal adhesion kinase (FAK) in Cav1-expressing cells
infected with H. pylori G27. These data corroborated that AGS/
Cav1 cells infected with CagA-delivery competent H. pylori
maintained their spread-out epithelial shape as compared with
the stressed elongated phenotype of Cav1/EV cells.
CagA-delivery competent H. pylori G27 triggers binding
of p120RhoGAP/DLC1 to Cav1 in human GC cells
Cav1 has been shown to be phosphorylated by cytosolic tyrosine
kinases (Src, Abl) at tyrosine 14 [49], and phosphorylated Cav1
and Src both activate the small GTPases Rho/Rac/Cdc42 which
regulate cytoskeletal functions [13,50]. To identify the underlying
molecular mechanism how Cav1 protects against CagA-related
cell stress, we assessed the signalling pathways initiated by CagA-
delivery proficient H. pylori G27. Infection of AGS cells evoked a
rapid phosphorylation of Cav1 in AGS/Cav1 cells and of Src in
both AGS/Cav1 and AGS/EV cells. This result indicated that
Cav1 acts downstream of CagA-dependent Src activation but
upstream of the activation of the small GTPases (Fig. 5A,B).
Consistent with this conclusion, protein levels of phosphorylated
JNK, which resides below of Src, were higher in AGS/EV cells
compared with AGS/Cav1 cells.
We were unable to detect a direct interaction or quantitative
colocalization of CagA protein or H. pylori G27 bacteria with Cav1
in CoIP or immunofluorescence experiments (Fig. 6A,B). Genta-
mycin protection assays revealed that the total amount of injected
Table 1. Histopathology of H. pylori gastritis.
Cav1 2/2 Cav1 +/+
Score 0 0/15 8/15
Score 1+ 4/15 4/15
Score 2+ 11/15 3/15
B6129 WT and Cav1-KO mice (n = 15 per genotype) were infected with H. pylori
SS1 for 11 months. Histopathological scores of gastritis were evaluated in H&E
stainings of sections from paraffin-embedded stomach tissue. Score 0 = no,
1+=mild, 2+=moderate, 3+= severe gastritis. Fisher Exact p = 0.001 (score 0
versus score 2+); Fisher Exact p = 0.002 (score 0 versus scores 1+,2+).
doi:10.1371/journal.ppat.1003251.t001
Figure 2. Loss of Cav1 promotes recruitment of macrophages to stomachs infected with H. pylori SS1. (A) Differential expression of
mRNAs in mouse gastric tissue upon an 11-month infection with H. pylori strain SS1. CT-values from RT-qPCRs on total RNA extracted from resected
stomachs were normalized to beta-2-microglobulin (b2M) and are presented as mean6 S.E. (n = 15 per group); *p,0.05 as indicated by brackets and
asterisks. Changes in mRNA levels were dependent on H. pylori-infection or genotype, respectively. (B) Cav1-KO mice infected with H. pylori SS1 for 11
month had pronounced infiltration of intramucosal macrophages. Immunohistochemistry (IHC) of F4/80-positive mononuclear cells. Representative
images are shown.
doi:10.1371/journal.ppat.1003251.g002
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intracellular CagA was also independent of Cav1’s presence
(Fig. 6C). Thus, Cav1 neither inhibited adhesion of H. pylori
bacteria to nor injection of CagA into the host cell, but rather
reduced the down-stream effects of CagA on intracellular
signalling.
To identify a candidate protein which confers protection against
CagA in a Cav1-dependent manner, a protein interaction screen
based on MALDI-MS was performed (Fig. 7A). AGS/Cav1 cells
were infected for 16 h with H. pylori G27 (MOI= 100) followed by
lysis of the cells at room temperature in MES-buffered 1% (v/v)
Triton-X100. Protein bands precipitated by Cav1 antiserum were
visualized by silver staining, and peptides were identified by
MALDI-MS as published previously [29]. A protein fragment of
,95 kDa contained peptides corresponding to variant 4 of p120
Rho GTPase-activating protein/deleted in liver cancer-1
(p120RhoGAP/DLC1) [51,52], a tumor suppressor associated
with focal adhesions and caveolae/lipid rafts [53]. DLC1 variant 4
(DLC1v4) has a predicted size of ,110 kDa and was enriched in
samples from cells that had been infected with H. pylori G27
compared to uninfected cells (Table S2). These results were
confirmed by CoIP of Cav1 and endogenous DLC1 protein in
AGS/Cav1 cells (Fig. 7B), indicating that H. pylori G27 evoked a
specific recruitment of DLC1 to Cav1 in infected human gastric
epithelial cells.
This result prompted us to amplify the cDNA of variant 4 of
human DLC1 [39] from human hepatoma HepG2 cells (Fig. 7C).
The cDNA was inserted into the expression vector pTarget (pT-
DLC1v4) followed by transient transfection into parental AGS or
HEK293 cells for 24 h. WB analyses detected expression of a
,110 kDa protein, consistent with the predicted size of DLC1v4
[39]. Transiently transfected AGS cells were then infected with H.
pylori G27 (MOI=100) for additional 16 h. Immunofluorescence
staining revealed that DLC1 per se did not inhibit formation of the
CagA-induced ‘‘humming bird’’ phenotype (1962% AGS/DLC1
versus 1962% AGS/EV; n= 3 per clone) compared with empty
vector-transfected cells (Fig. 8A,B). Instead, DLC1 promoted cell
spreading (2063% AGS/DLC1 versus 1162% AGS/EV;
*p= 0.0067; n= 3 per clone) consistent with its role in regulation
of focal adhesions [54,55,56] (Fig. 8A,C). Pull-down assays which
detected the activity of the small GTPases Rho/Rac/Cdc42
corroborated previous findings [56,57,58] that the CagA-profi-
cient H. pylori G27 strain was a weak activator of these GTPases
(data not shown). In sum, this data proposed that Cav1 inhibited
CagA-induced cytoskeletal changes through alterations in the
assembly or disassembly of focal adhesions via FAK rather than
via the small GTPase pathways.
H. pylori strains inhibit expression of Cav1 mRNA in vivo
and in vitro independently of CagA
We showed previously that Cav1 is frequently down-regulated
in human GC [37]. We therefore asked whether H. pylori infection
contributes to repression of the Cav1 gene. RT-qPCR analyses of
total RNA isolated from stomach tissue of uninfected mice and
mice infected with CagA-delivery incompetent H. pylori SS1 (for 11
month) were performed. Infected WT mice showed a significantly
reduced expression of Cav1 mRNA (1364 WT+H. pylori versus
Figure 3. Cav1 has no effect on adhesion of H. pylori to or on viability of human GC cells. (A) Proliferation. AGS/Cav1 and AGS/EV cells
(‘‘AGS clones’’) were infected with the cell-adapted CagA-delivery proficient H. pylori strain G27 strain for 48 h at MOI ratios of 1:100 to 1:2000. O.D.
values from colorimetric MTT assays were calculated as % survival 6 S.E. (n = 3); n.s. Cav1 versus EV. (B–C) Adhesion. AGS clones were infected with
G27 (MOI = 10) for 30 min, washed, and additionally incubated in fresh medium for 2 h before staining for immunofluorescence microscopy;
green=H. pylori, red= Cav1, blue =nuclei. Magnification 6630. Representative images (C) are shown together with a quantitative analysis (B).
Adherent bacteria per Cav1-positive and Cav1-negative cells were counted (.10 cells per field, total of 5 fields, n = 3 experiments) and presented as
mean 6 S.E.; n.s. Cav1 versus EV.
doi:10.1371/journal.ppat.1003251.g003
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3869 WT mock;*p= 0.0081; n = 15 per group) as compared to
the uninfected WT mice (Fig. 9A).
Similar results were obtained from in vitro studies. Two different
human GC cell lines with endogenous Cav1 expression, N87 and
MKN45, and MDCK cells were infected for 3 days with CagA-
delivery incompetent SS1 (Fig. 9B) or CagA-proficient G27
(Fig. 9C) H. pylori strains. In all cell lines, a robust reduction of
Cav1 mRNA expression (by 62 to 85%; H. pylori versus mock;
Figure 4. Cav1 protects human GC cells against CagA-induced cytoskeletal stress. (A–B) Cav1 inhibits CagA-induced cytoskeletal
responses (‘‘humming bird’’). AGS clones were infected with CagA-delivery proficient H. pylori G27 (MOI = 100) for 16 h and stained for
immunofluorescence microscopy; green= actin (phalloidin), red =Cav1, blue= nuclei. Magnification6630. Note the needle-like projections of AGS/EV
cells compared to spread-out epithelial AGS/Cav1 cells. Representative images (A) are shown above the quantitative analysis (B). Morphologies of all
cells (.10 cells/per field; total of 10 fields, n = 3 experiments) were counted and calculated in % ‘‘humming bird’’ 6 S.E. compared to the total cell
number; *p = 1.161028 AGS/Cav1 versus AGS/EV. (C) Cav1 inhibits H. pylori-induced production of IL8 mRNA. Cells were treated as in (A) for 6 h. CT-
values from RT-qPCRs were normalized to b2M and presented as mean 6 S.E. (n = 3 per clone); *p = 0.0176 AGS/Cav1 versus AGS/EV. (D) AGS/Cav1
cells have enhanced protein levels of phosphorylated (abbrev. P-) focal adhesion kinase (FAK), which promotes cell adhesion and spreading (see also
Figure S2), thereby opposing CagA-induced cytoskeletal stress. Representative Western Blots (WB) from total cell lysates (left) are show together
with a quantitative summary (right). O.D. values from bands in gels were calculated as -fold6 S.E. (n = 3) compared to time point 0 (uninfected cells);
* p = 0.0012 AGS/Cav1 versus AGS/EV.
doi:10.1371/journal.ppat.1003251.g004
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*p = 0.0001 to 0.0043; n= 3 per cell line) was observed compared
with uninfected cells. Similar results were obtained for Cav1
protein by WB (Fig. 9C).
The mouse-adapted H. pylori SS1 strain, which had been used
for our in vivo infections, contains the cagA gene, expresses cagA
mRNA (data not shown) but does not exert CagA protein-
dependent effector functions [40,59], whereas the cell-adapted
G27 strain delivers active CagA [56] into the host cells. We
therefore assessed whether Cav1 down-regulation is CagA-
dependent or not. The same three cell lines were infected with
H. pylori G27 Delta cagA (Fig. 9C) for three days. The CagA-
deleted strain also decreased the amounts of Cav1 mRNA
compared with uninfected cells (by 67 to 89%; H. pylori versus
mock; *p= 6.161025 to 0.0249; n= 3 per cell line), emphasizing
that the repression of the Cav1 gene was CagA-independent in vitro
and in vivo.
To determine whether the down-regulation of the Cav1 mRNA
was caused by inhibition of the Cav1 promoter, reporter assays
were performed (Fig. 9D). MKN45 cells were transfected with a
luciferase reporter plasmid pGL3 containing the human proximal
Cav1 promoter (pGL3-CAV1p) followed by a 16 h infection with
CagA-proficient H. pylori G27 (MOI= 100). As a positive control
served the pGL3-SeRE plasmid which harboured a CagA/stress-
responsive serum-response element (SeRE) [60]. H. pylori G27
infection significantly reduced the activity of the Cav1 promoter
(to 5361% H. pylori versus mock; *p = 2.761026 to 0.0052; n= 3)
compared with uninfected cells. Similar results were obtained from
HEK293 cells (Fig. 9D) and with CagA-delivery incompetent H.
pylori SS1 (data not shown). In contrast, the activity of the SeRE
was increased in H. pylori G27 infected MKN45 cells but not of an
unrelated control promoter from the human bile salt export pump
(BSEP) (Fig. 9D). This data confirmed that Cav1 gene expression
is down-regulated at the transcriptional level independently of
CagA.
H. pylori strains activate nuclear SREBP1 to repress the
human Cav1 promoter
Next, we were interested to identify the H. pylori-responsive
repressor of the Cav1 gene. H. pylori lowers cholesterol levels in the
host [26], and SREBP1 is activated by sterol deficiency to
negatively regulate Cav1 gene transcription [24]. We therefore
examined whether there is a higher binding rate of active nuclear
68 kDa SREBP1 to the sterol-responsive elements (SREs) of the
proximal human Cav1 promoter upon H. pylori infection. MKN45
cells were infected with H. pylori G27 for 24 h, and ChIP was
performed using antisera against SREBP1 and H4-acetyl histone
[45], a marker for transcriptionally active ‘‘open’’ chromatin.
Immunoprecipitated DNA was amplified by an whole genome
amplification approach [61] and used for genomic qPCR analysis
(Fig. 10A). Upon infection, we observed an increased binding of
SREBP1 to the sterol-responsive element-3 (SRE3) [24,62] of the
Cav1 promoter (2.560.5 H. pylori versus 0.460.2
mock;*p= 0.0093; n= 3). In contrast, the amount of H4-acetyl-
histone protein at the SRE3 was reduced upon infection (0.560.5
H. pylori versus 360.6 mock;*p= 0.0478; n = 3). These results
suggested that H. pylori inhibits transcription at this site by
recruitment of SREBP1 as a repressor of the Cav1 gene.
We corroborated these results using EMSA (Fig. 10B) [45].
MKN45 cells were infected with H. pylori G27 (MOI= 100) for
24 h. We could detect binding of protein to the SRE3
oligonucleotide from the Cav1 promoter exclusively in nuclear
extracts of infected cells. WB assays evinced that H. pylori G27
evoked accumulation of the active 68 kDa SREBP1 fragment in
the nucleus. RT-qPCR analyses demonstrated that the expression
of other bona fide SREBP1 target genes, which are positively
regulated by SREBP1, was also affected by H. pylori. The mRNAs
encoding 3-hydroxy-3-methyl-glutaryl-CoA synthase
(HMGCOAS), HMGCOA reductase (HMGCOAR), low density
lipoprotein receptor (LDLR) and acetyl-coenzyme A synthetase
(ACS) were up-regulated by CagA-proficient G27 wt, CagA-
deleted G27 Delta cagA and CagA-delivery deficient SS1 bacteria to
a maximum of 21-fold (H. pylori versus mock; *p = 0.0137 to 0.0196;
n = 3 per cell line) compared with uninfected cells (Fig. 10C).
Conclusively, these data emphasized that the Cav1 promoter was
inhibited by H. pylori-activated SREBP1 independently of CagA.
Discussion
In this study, we describe a novel role for Cav1 in H. pylori-
mediated gastritis and cell damage. Since many years, lipid rafts
have been shown to mediate uptake of pathogens (virus, bacteria,
parasites) and their toxins into host cells [8,10,11]. Internalization
of the two major toxins of H. pylori, VacA and CagA, via clathrin-
independent lipid raft-dependent endocytosis and the bacterial
type IV secretion system have been thoroughly validated using in
vitro systems, including the human gastric epithelial cell line AGS
[4,7]. However, the role of Cav1 in H. pylori infection in vitro and in
vivo remained unknown.
Recent reports on Cav1-deficient mice revealed a general
enhanced susceptibility to disease provoked by local or systemic
infection through certain pathogens including bacteria (Salmonella
typhimurium, Pseudomonas aeruginosa) or parasites (Trypanosoma cruzi)
Figure 5. CagA evokes phosphorylation of Cav1 and Src
independently of Cav1. (A–B) AGS clones were infected with
CagA-delivery proficient H. pylori G27 (MOI = 100) for 30 min to 48 h,
and cell lysates were analysed by WB. Representative WBs (A) are shown
together with the quantitative summary (B). O.D. values from bands in
gels were calculated as -fold 6 S.E. (n = 3) compared to time point 0
(uninfected cells). n.s. AGS/Cav1 versus AGS/EV.
doi:10.1371/journal.ppat.1003251.g005
Caveolin-1 and Helicobacter pylori
PLOS Pathogens | www.plospathogens.org 9 April 2013 | Volume 9 | Issue 4 | e1003251
[12,63,64,65,66,67,68]. Cav1-KO mice succumb to systemic
infection earlier and suffer from a more severe disease phenotype
than WT littermates. This sensitivity is presumably caused by
certain defects in either the innate or the adaptive immune system.
Since the predominant cell types with Cav1 expression are
macrophages [68] and endothelial cells [69], recruitment and
maturation of leukocytes (e.g. of regulatory T-cells [70]) may be
impaired in absence of Cav1. Loss of Cav1 in macrophages results
in defective phagocytosis [68,71] and altered release of nitric oxide
[72] and pro-inflammatory cytokines (TNFalpha, IL1beta)
[64,65]. Bacterial lipopolysaccharide has been reported to up-
regulate Cav1 expression in B-cells [23], and Cav1 was shown to
be associated with molecules of the synapse between T-cells
[21,73] and antigen-presenting cells. Thus, systemic absence of
Figure 6. Cav1 does not interact with CagA but inhibits downstream effects of CagA. (A) Cav1 does not quantitatively colocalize with H.
pylori or CagA. AGS/Cav1, MDCK and MKN45 cells were infected with CagA-delivery proficient H. pylori G27 (MOI = 10) or were transiently transfected
with GFP-CagA expression plasmid, followed by staining for confocal immunofluorescence microscopy; green=H. pylori/GFP-CagA, red=Cav1,
blue =nuclei. Magnification6630. Occasional colocalizations appear in yellow. (B) Cav1 does not directly interact with CagA. Cells were infected as in
(A) for 16 h (MOI = 100), and cell lysates were incubated with rabbit polyclonal CagA and Cav1 antisera. Precipitated proteins were detected by WB.
Representative CoIP experiments are shown. (C) Gentamycin protection assay. Cav1 has no impact on injection of CagA into the host cell. AGS clones
were infected with H. pylori G27 (MOI = 500) for 2 to 24 h, extensively washed with antibiotics, and intracellular CagA was determined by WB.
Representative results are shown next to the quantitative analyses. O.D. values from bands in gels were calculated as mean6 S.E. (n = 3 independent
experiments); n.s. AGS/Cav1 versus AGS/EV.
doi:10.1371/journal.ppat.1003251.g006
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Cav1 may impair immune responses to pathogens at multiple
levels.
Consistent with these reports, we found that Cav1-deficient
mice responded with an enhanced active chronic gastritis and
tissue damage to infection with the CagA-delivery deficient H.
pylori SS1 strain compared with WT littermates. This response was
accompanied by loss of parietal cells and foveolar hyperplasia. A
bias towards a T helper 1 immune response is expected to facilitate
the elimination of H. pylori bacteria from infected stomachs,
however, at the expense of a more severe gastritis in humans and
mice [74,75]. Consistent with this concept, we showed that Cav1-
KO animals had a reduced bacterial burden but an augmented
local infiltration of macrophages, marked formation of intramu-
cosal lymph follicles and production of chemokines (e.g.
RANTES/CCL5) in the infected gastric tissue. In line with the
known immunomodulatory effects of H. pylori [76,77,78], the
expression of CD-markers related to T helper (CD4/GATA4) and
regulatory T cells (CD25/FOXP3) was suppressed upon an 11-
month infection with H. pylori SS1, and this phenomenon was most
pronounced in Cav1-KO mice. Although more detailed studies
have to characterize the gastric milieu and the immune defects of
Cav1-KO mice, one may conclude that loss of Cav1 enhances the
susceptibility to pathogen-related disease by defects in the
Figure 7. Cav1 binds p120RhoGAP/DLC1 upon infection of
human GC cells with H. pylori G27. (A) Cav1 interacts with
p120RhoGAP/DLC1, a tumor suppressor and inhibitor of small GTPases
associated with focal adhesions and caveolae/lipid rafts. AGS/Cav1 cells
were infected with CagA-delivery competent H. pylori G27 (MOI = 100)
for 16 h. Total cell lysates were subjected to CoIP with rabbit polyclonal
Cav1-antiserum. Gels were silver stained, and peptides within a band
(,95 kDa) enriched in infected cells were analysed by MALDI-MS (see
also Table S2). (B) Validation of MALDI-MS. Cells were infected as (A),
and total cell lysates were subjected to CoIP using antibodies against
Cav1 and DLC1, respectively. Representative WBs show the ,110 kDa
DLC1 protein variant 4 (DLC1v4). (C) DLC1 mRNA and protein
expression. Top panel: RT-PCR gels detecting DLC1 mRNA variant 1
(full length according to [39]) in HEK293 cells, whereas DLC1v4 (short
form according to [39]) was expressed in all human cancer cell lines
tested. Bottom panel: Cells were transiently transfected with the
expression vector pTarget-DLC1v4 (pT-DLC1v4). Representative RT-PCR
and WB gels visualizing the transfected DLC1v4 mRNA and the
,110 kDa DLC1v4 protein are shown.
doi:10.1371/journal.ppat.1003251.g007
Figure 8. DLC1 rescues human GC cells from CagA-related
adhesion defects. (A) AGS/EV cells were transiently transfected with
pT-DLC1v4 plasmid for 24 h, followed by infection with CagA-delivery
competent H. pylori G27 for additional 16 h and staining for
immunofluorescence microscopy; green = actin (phalloidin), blue = -
nuclei. Magnification6630. (B–C) Representative immunofluorescence
images (A) are presented together with quantitative analyses of
‘‘humming bird’’ (B) and cell spreading (C) morphologies. Cell
phenotypes were counted for at least 10 cells per field (total of 10
fields) and calculated as % 6 S.E. (n = 3 experiments) of total cells;
p = 0.0067 AGS/EV versus AGS/DLC1.
doi:10.1371/journal.ppat.1003251.g008
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generation of a pathogen-directed adaptive T-cell immune
response.
H. pylori has developed many strategies to evade the host’s
immune system [78]. It has been described that H. pylori is
auxotrophic for cholesterol and extracts cholesterol from the host
cell membrane to actively inhibit phagocytosis and modify the
generation of adaptive T-cell responses [26,79]. Depletion of host
cell membranes from cholesterol inhibits CagA-dependent effects
on cell elongation and IL8 production in vitro [27,80]. These
observations led us to the hypothesis that H. pylori may create a
cholesterol-deficient microenvironment in/around infected cells
which activates the cholesterol deficiency sensor SREBP1. Indeed,
we demonstrated that SREBP1 was activated by H. pylori to down-
regulate Cav1 gene expression in vitro and in vivo. This effect was
independent of H. pylori’s major oncoprotein CagA, but was strain-
specific, because it was not observed upon infection with other
Helicobacter species such as H. hepaticus (unpublished observation).
In contrast to the CagA and VacA delivery-competent G27 strain,
SS1 bacteria fail to exert bona fide effector functions of CagA and
VacA proteins within host cells [40,59,81]. This defect may be
attributed to the type IV secretion system or toxin delivery. Thus,
further studies are necessary to identify the factors which are
responsible for activation of SREBP1 by SS1.
To explore one of the in vitro mechanisms how Cav1 protects
against H. pylori-related cell damage, we demonstrated that Cav1
neither interfered with adhesion of H. pylori SS1 or G27 bacteria to
human gastric epithelial cells nor with injection of G27-derived
CagA protein into the cytosol. Instead, Cav1 inhibited the down-
stream effects of intracellular CagA on the rearrangement of the
actin cytoskeleton and on the production of IL8. This in vitro
Figure 9. H. pylori strains down-regulate Cav1 gene expression in vitro and in vivo independently of CagA. (A) Reduced expression of
mouse Cav1 mRNA after an 11-month infection with CagA-delivery defective H. pylori strain SS1. CT-values from RT-qPCRs on total RNA extracted
from resected stomachs were normalized to b2M and presented as mean 6 S.E. (n = 15 per group); *p = 0.0081 KO versus WT. (B–C) CagA-proficient
G27 and CagA-delivery incompetent SS1 H. pylori strains both down-regulate Cav1 mRNA and protein expression in human GC cell lines
independently of CagA. MDCK, N87 and MKN45 cells were infected with the respective H. pylori strain (MOI = 100) for the indicated times. Left: CT-
values from RT-qPCRs on total RNA (3 days upon infection) were normalized to b2M and calculated as % 6 S.E. (n = 3 per cell lines); (B) *p = 0.0043
(MDCK), 0.0001 (N87) and 0.0345 (MKN45), (C) *p,0.05 for all three cell lines; H. pylori versus mock. Right: Representative WBs are shown. (D) H. pylori
inhibits Cav1 promoter activity. HEK293 and MKN45 cells were transiently transfected for 24 h with pGL3-CAV1p, SeRE or BSEP firefly luciferase
reporter plasmids together with renilla control plasmid, followed by infection with H. pylori G27 (MOI = 100) for additional 16 h. Firefly luciferase
activity was normalized to renilla and is presented as % 6 S.E. (n = 3); *p = 0.002 (Cav1) for HEK293, 2.761026 (Cav1) and 0.0052 (SeRE) for MKN45, H.
pylori versus mock.
doi:10.1371/journal.ppat.1003251.g009
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phenomenon of spike-like cell elongation (‘‘humming bird’’) is
supposed to resemble, at least in part, an in vivo event which
facilitates access of live H. pylori into favourable niches of the
gastric epithelium for successful persistence of the microorganism
within the host organ [78]. We found that Cav1 did not directly
interact with CagA. Instead, Src kinase was phosphorylated on
specific tyrosine residues upon infection with H. pylori G27
independently of Cav1. Cav1 altered the activation status of two
Figure 10. H. pylori strains down-regulate Cav1 promoter activity via activation of SREPB1. (A) H. pylori enhances binding of SREBP1 to
one of the three sterol-responsive elements (SRE3) [24,62] in the proximal human Cav1 promoter. ChIP: MKN45 cells were infected with H. pylori G27
(MOI = 100) for 16 h, and IP was performed in total cell lysates with rabbit polyclonal acetyl-H4-histone, SREBP1 or control IgG. CT-values from qPCR
of IP-ed DNA were normalized to the CT-values of input DNA and were calculated as mean 6 S.E. (n = 3) of protein-DNA complex pull-down by H.
pylori compared to empty bead and uninfected controls; *p = 0.0093 for SREBP1 and p= 0.0478 for acetyl-H4-histone, H. pylori versus mock. Insert:
Representative WBs of nuclear extracts showing mature 68 kDa SREBP1 in the nucleus of H. pylori G27-infected MKN45 cells. (B) EMSA: MKN45 cells
were infected with H. pylori G27 for 16 h, and nuclear extracts were incubated with biotin (BIO)-labelled oligonucleotide (SRE3) [62] from the human
Cav1 promoter and an excess of unlabelled competitor oligonucleotides (SRE3-WT=wild-type; SRE3-MUT=mutant). Insert: Representative WBs of
whole cell lysates showing accumulation of active 68 kDa SREBP1 in H. pylori G27-infected MKN45 cells. (C) H. pylori also regulates mRNA expression
of other cognate SREBP1 target genes. CT-values from RT-qPCRs on total RNA extracted from cells infected with CagA-delivery competent G27 wt,
CagA-deleted G27 Delta cagA or CagA-delivery deficient SS1 H. pylori strains were normalized to b2M and presented as % 6 S.E. (n = 15 per group);
*p = 0.0137 to 0.0196, H. pylori versus mock.
doi:10.1371/journal.ppat.1003251.g010
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kinases downstream of Src, it reduced phosphorylation of JNK but
enhanced that of FAK, proposing that Cav1 blunts stress-related
CagA-signalling downstream of active Src but promotes cell
adhesion.
Mechanistically, we evinced that the CagA-proficient H. pylori
G27 evoked the recruitment of p120RhoGAP/DLC1 to Cav1.
DLC1 has been initially described as an inhibitor of small
GTPases which localizes to focal adhesions and lipid raft/caveolae
membrane microdomains [53,54,55,82]. Cav1 may thus promote
the function/activity of DLC1 as a tumor suppressor via direct
interaction through a bona fide Cav1-binding motif [53] identified
in DLC1. Unexpectedly, DLC1 did not inhibit the formation of
fiber-like elongations in cells infected with CagA-delivery compe-
tent H. pylori G27 which have been attributed to activation of the
small GTPases RhoA/Rac1/Cdc42 by CagA. This result may be
explained by previous reports [56,57,58] showing that the G27
strain is only a weak activator of those GTPases. Instead, DLC1
promoted cell adhesion and spreading. This phenotype was
presumably caused by changes in the assembly and/or disassembly
of focal adhesions, since FAK is a direct target of H. pylori’s CagA
[48] and, together with other components of focal adhesions, such
as talin and tensins, directly interacts with DLC1 [53,54,55].
Conclusively, Cav1 seems to exert its protective effect against
intracellular CagA effector functions on the actin cytoskeleton via
DLC1. Cav1 did not require direct interaction with CagA to exert
its pro-adhesive effects. Hence, the Cav1/DLC1 complex may also
protect cells against CagA-delivery deficient H. pylori strains,
including SS1, which have been used in our in vivo study. However,
future experiments have to explore this assumption.
Cav1 is a ubiquitous adapter molecule in many immune
receptor signalling pathways. One may thus speculate that H. pylori
exploits down-regulation of Cav1 to subvert the host immune
system or to enhance the signalling efficiency of its virulence
factors in gastric epithelial cells. In case of clinical isolates from
infected individuals, the pre-mouse Sydney strain-1 (PMSS1) or
G27 [32,77] those virulence factors may comprise CagA and
VacA, in case of SS1, other yet unknown bacterial proteins could
be involved.
Loss of Cav1, in its function as a tumor suppressor and inhibitor
of growth factor receptor signalling which stabilizes cell-cell and
cell-matrix contacts, is a hallmark of many human cancers
including GC [19]. Absence of Cav1 in primary tumors promotes
cell proliferation and enables clonal expansion [15,19]. Similar to
Cav1, DLC1 is a tumor suppressor silenced or deleted in many
human cancer entities including GC, e.g. by gene methylation
[39,51]. Thus, down-regulation of Cav1 by H. pylori in stomach
tissue in vivo may be part of an early molecular sequence of events
in the transition of inflammation to GC also in humans.
We would like to emphasize that the aim of the current work
was not the identification of novel virulence factors in the SS1 H.
pylori strain, which are unknown since 15 years, but rather to
clarify the role of Cav1 in H. pylori-induced gastric pathology by
directly comparing the lesions obtained in the Cav1-KO mice to
the results of other researchers who used SS1 H. pylori strain in
other mouse genotypes or backgrounds (C57BL/6, B6129, BALB/
c) [28,33,34,83]. The Cav1-KO mice did not progress to gastric
neoplasia with CagA-delivery incompetent SS1. We therefore
additionally investigated the molecular mechanisms of Cav1 on
CagA-delivery proficient G27 strain signalling in gastric epithelial
cell lines, in order to strengthen the relevance of our findings to the
situation in humans, where CagA-injection competent strains are
associated with development of GC [1,3,5]. In the future, we shall
infect Cav1-KO mice with PMSS1, an H. pylori strain which
injects functionally active CagA protein into the host gastric
epithelium [77,84,85].
Our study describes two different aspects of Cav1’s role in
stomach disease: (i) first, an in vivo protective role against H. pylori-
induced inflammation which was independent of CagA/VacA,
and (ii) second, an in vitro protective role against H. pylori-induced
cytoskeletal rearrangement which was dependent on CagA and
DLC1. These data comprise two separate aspects of H. pylori
biology which are not easily reconciled. Nevertheless, our major
objective was to present a first description of a beneficial role for
Cav1 in H. pylori-related diseases, against gastritis in vivo and
cytoskeletal stress in vitro, rather than to elaborate on the potential
virulence mechanisms of SS1. To our knowledge, this novel role of
Cav1 in H. pylori biology was previously unknown and may thus
provide the initial basis for further detailed in vivo and in vitro
studies
We have been well aware of the fact that H. pylori strain SS1 is
incapable of exerting CagA and VacA-dependent effector
functions [81,83,86,87]. Over the years, a consensus has been
reached that SS1 expresses CagA mRNA but does not inject
functional CagA protein into the host cells via the type IV
secretion system [40]. Similarly, SS1 is devoid of VacA-dependent
vacuolating cytotoxicity and induction of IL8 [81]. Nevertheless,
SS1 is still able to induce severe gastric pathology in vivo
independently of these two important virulence factors, especially
after chronic infection and persistent colonization [35,59]. The
SS1 virulence factors responsible for gastric inflammation, tissue
damage and carcinogenesis have remained unknown since the
introduction of the strain as a standardized reference model in
1997 [32].
Several alternative mechanisms of virulence have been
described for SS1. For example, SS1 up-regulates matrix-
metalloproteinases (MMPs) inducing inflammation and tissue
damage independently of CagA [86]. Moreover, SS1 per se evokes
mutations and genotoxic stress in mice, a pathology which may
contribute to pre-neoplastic alterations in the gastric mucosa
[33,88]. Interestingly, the CagA-delivery competent PMSS1 strain
promotes genotoxic stress as well independently of its common
virulence factors CagA and VacA [89]. Instead, bacterial adhesion
factors were necessary to achieve the mutagenic effect [89].
Nevertheless, SS1 bacteria deficient in certain adhesion factors still
evoked severe gastric pathology in vivo (here in gerbils) [90], and
the presence of CagA or VacA had no effect on the ability of HP
strains to adhere or invade gastric epithelial cells in vitro [87]. Thus,
the quest for pathogenic virulence mechanisms of SS1 is still
ongoing.
These reports demonstrated, that single major virulence factors
like CagA or VacA are not the exclusive responsible agents for the
observed gastric histopathology induced by SS1, but rather a
combination of so far unknown bacterial factors and last but not
least the host immune response. Relating to the latter, H. pylori-
induced changes in cholesterol content at host cell membranes and
the well-described immunomodulating effect of H. pylori may be of
higher importance for pathogenicity than the action of single
cytotoxins/oncoproteins. Confirming this assumption, we showed
that SS1 (CagA2/VacA2) and G27 (CagA+/VacA+) strains both
down-regulated SREBP1-mediated Cav1 gene expression inde-
pendently of CagA/VacA, constituting a potential novel patho-
genic mechanism of H. pylori which acts independently of classical
virulence factors.
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Supporting Information
Figure S1 Cav1 protects against gastric injury in vivo.
(A–B) Cav1-KO mice are susceptible to indomethacin-mediated
gastric injury. C57BL/6 WT and B6129 Cav1-KO mice received
an i.p. injection of 35 mg/kg indomethacin (n = 9 per genotype) or
NaCl (n = 3 per genotype) for 24 h, respectively. H&E stainings
from paraffin sections of gastric tissue were evaluated for damage
scores [30,91]: 0+ no inflammation, 1+ superficial erosive gastritis,
2+ moderate discrete erosive gastritis, 3+ severe gastritis with
elongated erosions and ulcerations. Representative H&E stainings
(A) and damage scores (B) for individual mice are presented;
*p = 0.0161 WT versus KO; magnifications 1006. (C) Cav1-KO
mice express higher levels of gastric mRNAs (Pparg, Tff2) involved
in mucosa regeneration. The CT-values from RT-qPCRs on total
RNA extracted from resected stomach tissue were normalized to
b2M and presented as mean 6 S.E. (n = 9 per group); *p= 0.0008
for Pparg and 0.0048 for Tff2, WT versus KO. (D) Cav1-KO and
WT mice produce similar levels of systemic pro-inflammatory
cytokines. Serum cytokines were measured by ELISA and values
were calculated as pg/ml 6 S.E. (n = 9 per group).
(TIF)
Figure S2 Cav1 promotes cell adhesion and wound
closure in vitro. (A) Cell adhesion. AGS/Cav1 and AGS/EV
cells were seeded on tissue culture dishes for 6 h. The number of
adherent cells was counted as mean 6 S.E. (n = 3); *p = 0.0394,
Cav1 versus EV. (B) Wound closure. Confluent AGS/Cav1 and
AGS/EV cell monolayers were injured by a 5 mm wide scratch.
Wound closure by cell migration was measured after 24 h in
micrometer and calculated as % 6 S.E. (n = 3); *p = 0.0061, Cav1
versus EV.
(TIF)
Table S1 Oligonucleotides. DNA-sequences of 59-(forward)
and 39-(reverse) primers for detection of human, mouse and H.
pylori genes by RT-qPCR are listed. Oligonucleotide sequences
from the human CAV1 gene promoter containing SREs were used
for performance of EMSA and ChIP assays.
(DOC)
Table S2 DLC1 peptides identified by MALDI-MS. The
amino acid sequence and the localization of peptides precipitated
in CoIP experiments using Cav1 as a bait are presented. Peptides
overlapped with both variant 1 and variant 4 of the human DLC1
protein. * Mascot total ion score by GPS Explorer 2 software; #
Location of peptides identified by MALDI-MS in the coding
sequence (CDS) of human DLC1 protein variants.
(DOC)
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